Thomas Bever, Partner, Chilivis Cochran Larkins & Bever LLP, to Speak at KC’s Emerging Issues in Health Care Enforcement: New Tactics, New Theories Live Webcast
New York, NY, August 07, 2015 --(PR.com)-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Thomas Bever, Partner, Chilivis Cochran Larkins & Bever LLP will speak at the Knowledge Congress’ webcast entitled: “Emerging Issues in Health Care Enforcement: New Tactics, New Theories Live Webcast.” This event is scheduled for September 25, 2015 from 10:00 AM -12:00 PM (ET).
For further details, please visit:
http://theknowledgegroup.org/event_name/emerging-issues-in-health-care-enforcement-new-tactics-new-theories-live-webcast/
About Thomas Bever
Tom Bever is a former federal prosecutor who focuses his practice on White Collar Criminal Defense and commercial litigation. He is listed in U.S. News Best Lawyers in America for Criminal Defense for White Collar Crime (2006–2015) and for Commercial Litigation (2009–2014), ranked as a Georgia Super Lawyer (Criminal Defense: White Collar), (2005-2015), Tom is in Chambers USA for White Collar Crime & Government Investigations. He has had a top AV Preeminent rating by Martindale Hubbell for more than 20 consecutive years. He is a member of the Litigation Counsel of America, a trial honorary society.
Tom earned his JDA and MBA from the University of Virginia, and practiced in Atlanta with Alston & Bird. He then served in the Criminal Division of the United States Attorney’s Office for the Northern District of Georgia, prosecuting fraud, public corruption, and general crimes. The U.S. Department of Justice awarded him a Special Commendation for his prosecution of a major FHA mortgage loan fraud case. Tom later served as Associate Counsel in the Office of Independent Counsel conducting the “Iran/Contra” investigation.
Tom returned to private practice with Chilivis Cochran Larkins & Bever LLP. Tom is focused primarily on White Collar criminal defense, representing individual and corporate clients in all stages of criminal investigations in federal and state courts, from the initiation of the investigation through trial. He also represents clients in civil litigation and trials, as well as administrative hearings and regulatory matters. Tom has served as lead counsel on behalf of companies on a variety of internal investigations. His cases have primarily been in healthcare, government contracting, securities, tax, environmental, and commercial disputes.
Tom speaks and appears regularly at a variety of professional seminars. These have included the National Seminar on the Federal Sentencing Guidelines, the American Bar Association’s Healthcare Fraud Institute, and annual seminars in Georgia on White Collar Crime, Healthcare Fraud, Federal Criminal Practice, and Internal Corporate Investigations.
About Chilivis, Cochran, Larkins & Bever LLP
Chilivis, Cochran, Larkins & Bever LLP is a litigation boutique with a broad client base of businesses and individuals, including executives, corporate officers, employees, physicians, physician practice groups, attorneys, and others facing high-stakes civil, white collar criminal, business litigation, health care, and administrative law matters in federal and state courts. Three of our five partners are former federal prosecutors in Georgia. All five partners are named as Super Lawyers. Three of our partners are in U.S. News & World Report as Best Lawyers in America. The first has both defended and represented relators in false claims act cases since the early 1990s.
Event Synopsis:
Increasingly, federal departments are addressing the frequent, persistent and growing complexity of healthcare fraud. The Department of Justice (DOJ) recovered over $2.3 billion in False Claims Act cases while the Federal Trade Commission (FTC) challenged several hospital and physician practice mergers and pursued anti-competitive pharmaceutical patent settlements. There is also a trend toward aggressive civil enforcement supplemented with new criminal prosecution methods, such as HEAT, previously confined to organized crime and narcotics trafficking organizations.
The agencies are not only focusing on professionals involved in healthcare fraud but also on the current Good Manufacturing Practices (cGMP) of pharmaceutical and medical companies. Recently, cGMP problems have become a source of health care fraud enforcement. The Food and Drug Administration (FDA) is intensifying its prosecution of cGMP laxity and the DOJ is viewing cGMP violations as potential civil or criminal issues.
Hence, the challenge of compliance is an increasing problem for everyone in the healthcare industry. Avoiding litigation for fraud or failure to comply with regulations is getting harder than ever.
In this CLE course, a panel of notable leaders and professionals assembled by The Knowledge Group will provide the audience with an in-depth review and discussion of the rigid, focused, and sophisticated Healthcare Fraud Enforcement Tactics. The speakers will also provide the audience with a set of best practices to remain in compliance and to avoid healthcare enforcement pitfalls in 2016 and beyond.
Key topics include:
§ The Affordable Care Act created new provisions the government plans to use against health fraud, waste, and abuse. These provisions include new tougher criminal sentences for health fraud convictions, and tougher suspension authority and screening measures over providers.
§ In June 2015, the DOJ and OIG together coordinated an unprecedented one day takedown of 243 people nationwide for alleged health fraud worth $712 million. The takedown highlights the government’s focus on multiple types of fraud, especially including cases involving medical necessity, home health agencies, and Medicare Part D schemes.
§ This year, the Office of Inspector General (OIG) has created a new task force that will primarily use both Civil Monetary Penalties and Exclusions from federal healthcare programs to go after alleged health fraud and abuse. The OIG announced that this new task force plans to target individual physicians instead of large healthcare systems. Once targeted, the OIG will pursue administrative actions that are easier to prosecute than actions under the False Claims Act.
§ Federal agencies are expanding the use of Data Analytics in an effort to become more proactive in detecting potential healthcare fraud. CMS’s Fraud Prevent System and OIG’s Medicare Fraud Strike Force both have a long-term goal to increase the use of technology and data to sniff out fraud sooner instead using the old “pay-and-chase” model of enforcement.
§ Unique enforcement risks facing executives in the health care industry in light of DOJ’s increasing invocation of the Park doctrine and HHS OIG’s broadening authority to exclude individuals from participation in federally funded health care industry
§ Increased focus on violations of current Good Manufacturing Practices as a basis for criminal liability as well as liability under the False Claims Act
§ Current trends in criminal and civil enforcement against “off-label promotion” by both drug and device manufacturers in light of recent caselaw
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: http://theknowledgegroup.org/
For further details, please visit:
http://theknowledgegroup.org/event_name/emerging-issues-in-health-care-enforcement-new-tactics-new-theories-live-webcast/
About Thomas Bever
Tom Bever is a former federal prosecutor who focuses his practice on White Collar Criminal Defense and commercial litigation. He is listed in U.S. News Best Lawyers in America for Criminal Defense for White Collar Crime (2006–2015) and for Commercial Litigation (2009–2014), ranked as a Georgia Super Lawyer (Criminal Defense: White Collar), (2005-2015), Tom is in Chambers USA for White Collar Crime & Government Investigations. He has had a top AV Preeminent rating by Martindale Hubbell for more than 20 consecutive years. He is a member of the Litigation Counsel of America, a trial honorary society.
Tom earned his JDA and MBA from the University of Virginia, and practiced in Atlanta with Alston & Bird. He then served in the Criminal Division of the United States Attorney’s Office for the Northern District of Georgia, prosecuting fraud, public corruption, and general crimes. The U.S. Department of Justice awarded him a Special Commendation for his prosecution of a major FHA mortgage loan fraud case. Tom later served as Associate Counsel in the Office of Independent Counsel conducting the “Iran/Contra” investigation.
Tom returned to private practice with Chilivis Cochran Larkins & Bever LLP. Tom is focused primarily on White Collar criminal defense, representing individual and corporate clients in all stages of criminal investigations in federal and state courts, from the initiation of the investigation through trial. He also represents clients in civil litigation and trials, as well as administrative hearings and regulatory matters. Tom has served as lead counsel on behalf of companies on a variety of internal investigations. His cases have primarily been in healthcare, government contracting, securities, tax, environmental, and commercial disputes.
Tom speaks and appears regularly at a variety of professional seminars. These have included the National Seminar on the Federal Sentencing Guidelines, the American Bar Association’s Healthcare Fraud Institute, and annual seminars in Georgia on White Collar Crime, Healthcare Fraud, Federal Criminal Practice, and Internal Corporate Investigations.
About Chilivis, Cochran, Larkins & Bever LLP
Chilivis, Cochran, Larkins & Bever LLP is a litigation boutique with a broad client base of businesses and individuals, including executives, corporate officers, employees, physicians, physician practice groups, attorneys, and others facing high-stakes civil, white collar criminal, business litigation, health care, and administrative law matters in federal and state courts. Three of our five partners are former federal prosecutors in Georgia. All five partners are named as Super Lawyers. Three of our partners are in U.S. News & World Report as Best Lawyers in America. The first has both defended and represented relators in false claims act cases since the early 1990s.
Event Synopsis:
Increasingly, federal departments are addressing the frequent, persistent and growing complexity of healthcare fraud. The Department of Justice (DOJ) recovered over $2.3 billion in False Claims Act cases while the Federal Trade Commission (FTC) challenged several hospital and physician practice mergers and pursued anti-competitive pharmaceutical patent settlements. There is also a trend toward aggressive civil enforcement supplemented with new criminal prosecution methods, such as HEAT, previously confined to organized crime and narcotics trafficking organizations.
The agencies are not only focusing on professionals involved in healthcare fraud but also on the current Good Manufacturing Practices (cGMP) of pharmaceutical and medical companies. Recently, cGMP problems have become a source of health care fraud enforcement. The Food and Drug Administration (FDA) is intensifying its prosecution of cGMP laxity and the DOJ is viewing cGMP violations as potential civil or criminal issues.
Hence, the challenge of compliance is an increasing problem for everyone in the healthcare industry. Avoiding litigation for fraud or failure to comply with regulations is getting harder than ever.
In this CLE course, a panel of notable leaders and professionals assembled by The Knowledge Group will provide the audience with an in-depth review and discussion of the rigid, focused, and sophisticated Healthcare Fraud Enforcement Tactics. The speakers will also provide the audience with a set of best practices to remain in compliance and to avoid healthcare enforcement pitfalls in 2016 and beyond.
Key topics include:
§ The Affordable Care Act created new provisions the government plans to use against health fraud, waste, and abuse. These provisions include new tougher criminal sentences for health fraud convictions, and tougher suspension authority and screening measures over providers.
§ In June 2015, the DOJ and OIG together coordinated an unprecedented one day takedown of 243 people nationwide for alleged health fraud worth $712 million. The takedown highlights the government’s focus on multiple types of fraud, especially including cases involving medical necessity, home health agencies, and Medicare Part D schemes.
§ This year, the Office of Inspector General (OIG) has created a new task force that will primarily use both Civil Monetary Penalties and Exclusions from federal healthcare programs to go after alleged health fraud and abuse. The OIG announced that this new task force plans to target individual physicians instead of large healthcare systems. Once targeted, the OIG will pursue administrative actions that are easier to prosecute than actions under the False Claims Act.
§ Federal agencies are expanding the use of Data Analytics in an effort to become more proactive in detecting potential healthcare fraud. CMS’s Fraud Prevent System and OIG’s Medicare Fraud Strike Force both have a long-term goal to increase the use of technology and data to sniff out fraud sooner instead using the old “pay-and-chase” model of enforcement.
§ Unique enforcement risks facing executives in the health care industry in light of DOJ’s increasing invocation of the Park doctrine and HHS OIG’s broadening authority to exclude individuals from participation in federally funded health care industry
§ Increased focus on violations of current Good Manufacturing Practices as a basis for criminal liability as well as liability under the False Claims Act
§ Current trends in criminal and civil enforcement against “off-label promotion” by both drug and device manufacturers in light of recent caselaw
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: http://theknowledgegroup.org/
Contact
The Knowledge Group
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.theknowledgegroup.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.theknowledgegroup.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Contact
Categories